Chai Gadde
Chai Gadde has been at the forefront of several business endeavors and continues to innovate in the healthcare industry. His dedication to providing quality care to patients is the backbone of his business philosophy and what drives him to create value. Chai has a vision for the future of health that is smart, efficient, and most importantly, provides the best possible outcomes for patients.
Professionally, Chai Gadde is the founder and CEO of Biotek reMEDys, a company focused on treating rare diseases. Chai's industry affiliations include American Managed Care Pharmacy, American Pharmaceutical Association, Delaware Pharmacists Society, National Home Infusion Association.
Chai contributes to various philanthropic and service organizations including the Delaware Community Foundation, Premier Charities, and Social Venture Partners. He also serves on the Board of Trustees for the University of Delaware, the Board of Trustees at The Sanford School, and the University of Delaware Biopharmaceutical Innovation Board.
Additionally, Chai is the Chairman of the Board at Innovative Precision Health, a healthcare analytics company that delivers multi-dimensional patient performance data and comparative efficacy metrics to optimize the continuum of care.
Originally from Hyderabad, India, Chai earned his undergraduate degree in pharmacy from Bangalore University, did graduate work in pharmaceutical industrial manufacturing at Long Island University, and holds a Master of Business Administration from the University of Delaware.
-
Multiplying Good
Board of Governors -
University of Delaware
Former member Board of Trustees -
Sanford School
Member Board of Trustees -
Delaware Institute of Medical Education and Research
Board of Directors